{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:16Z","timestamp":1746417736312,"version":"3.40.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,23]]},"abstract":"<jats:p>The objective for the study was to analysis the epidemiology of adenosarcoma, and independent prognostic factors and impact of lymph node dissection (LND) of uterine adenosarcoma. Cases of patients with primary adenosarcoma were obtained from the Surveillance, Epidemiology, and End Results (SEER) database from 2000 to 2016. Overall survival was analyzed by the Kaplan\u2013Meier method and log-rank test. The differences in baseline covariates between the 2 groups were adjusted by inverse probability of treatment weighting method. The prognostic factors were identified by univariate and multivariate Cox regression analysis and hazard ratio and 95% confidence interval (CI) of covariates were also estimated. 1129 patients with pathological primary adenosarcoma between 2000 and 2016 were identified from the surveillance, epidemiology, and end results database. The only 4 patients were male. 1027 patients with primary uterine adenosarcoma, and 53.1% underwent LND and only 3.5% patients were with positive lymph node. Age, marital status, largest tumor size, tumor grade, T stage and chemotherapy were significantly correlated with survival. Race, tumor number, LND, and radiotherapy did not affect overall survival in patients. Inverse probability of treatment weighting-adjusted K-M curve showed that LND did not improve survival and lymph node metastasis (LNM) did not affect survival. The majority of primary adenosarcoma patients are female with high incidence of uterus and rare incidence of distant metastasis. Age, marital status, tumor size, T stage, grade, and chemotherapy are independent prognostic factors of uterine adenosarcoma. LNM was not a significant prognostic risk factor, and LND did not benefit survival.<\/jats:p>","DOI":"10.1097\/md.0000000000030607","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:12:17Z","timestamp":1663942337000},"page":"e30607","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma"],"prefix":"10.1097","volume":"101","author":[{"given":"Hanjie","family":"Hu","sequence":"first","affiliation":[{"name":"Key Laboratory of Gene Editing Screening and R&D of Digestive System Tumor Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Hepatobiliary Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhewen","family":"Wei","sequence":"additional","affiliation":[{"name":"Key Laboratory of Gene Editing Screening and R&D of Digestive System Tumor Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Hepatobiliary Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Gene Editing Screening and R&D of Digestive System Tumor Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Hepatobiliary Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Gynecological Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0046-8177(90)90198-E","article-title":"Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature.","volume":"21","author":"Clement","year":"1990","journal-title":"Hum Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.humpath.2009.03.018","article-title":"Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.","volume":"40","author":"D\u2019Angelo","year":"2009","journal-title":"Hum Pathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2017.10.009","article-title":"A case of a primary hepatic so-called adenosarcoma with heterotopic ossification: possibly of biliary adenofibroma origin.","volume":"73","author":"Meguro","year":"2018","journal-title":"Hum Pathol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11912-016-0552-7","article-title":"Uterine Adenosarcoma: a Review.","volume":"18","author":"Nathenson","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000494067","article-title":"Uterine adenosarcoma.","volume":"41","author":"Ulrich","year":"2018","journal-title":"Oncol Res Treat"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-018-4037-y","article-title":"Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.","volume":"18","author":"Mandato","year":"2018","journal-title":"BMC Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review.","volume":"116","author":"D\u2019Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/1097-0142(197410)34:4<1138::AID-CNCR2820340425>3.0.CO;2-9","article-title":"M\u00fcllerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of Mullerian mixed tumor.","volume":"34","author":"Clement","year":"1974","journal-title":"Cancer"},{"key":"R9-20250504","first-page":"617","article-title":"M\u00fcllerian adenosarcoma: a review of cases and literature.","volume":"35","author":"Huang","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/14737140.2018.1518136","article-title":"Prognostic factors for uterine adenosarcoma: a review.","volume":"18","author":"Nathenson","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7150\/ijbs.39773","article-title":"A real-world study on diagnosis and treatment of uterine sarcoma in Western China.","volume":"16","author":"Li","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-020-02783-y","article-title":"Primary biliary adenosarcoma of the liver-a special and new entity.","volume":"477","author":"Oliveira","year":"2020","journal-title":"Virchows Arch"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004347-199204000-00001","article-title":"Adenosarcoma of the uterus: a gynecologic oncology group clinicopathologic study of 31 cases.","volume":"11","author":"Kaku","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2010.07.001","article-title":"Long-term outcome and natural history of uterine adenosarcomas.","volume":"119","author":"Arend","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.2001.6334","article-title":"Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.","volume":"83","author":"Krivak","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3802\/jgo.2010.21.2.125","article-title":"Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature.","volume":"21","author":"Duggal","year":"2010","journal-title":"J Gynecol Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2012.12.036","article-title":"Management of uterine adenosarcomas with and without sarcomatous overgrowth.","volume":"129","author":"Tanner","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.10.022","article-title":"Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.","volume":"135","author":"Carroll","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.3390\/cancers13225808","article-title":"Uterine preservation treatments in sarcomas: oncological problems and reproductive results: a systematic review.","volume":"13","author":"Dondi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge.","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2016.10.013","article-title":"Survival of women with Mullerian adenosarcoma: a National Cancer Data Base study.","volume":"143","author":"Seagle","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas.","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2017.01.012","article-title":"Significance of lymph node metastasis on survival of women with uterine adenosarcoma.","volume":"144","author":"Machida","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1525-1438.1999.09885.x","article-title":"Adenosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases.","volume":"9","author":"Blom","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/IGC.0000000000001306","article-title":"The importance of lymphovascular invasion in uterine adenosarcomas: analysis of clinical, prognostic, and treatment outcomes.","volume":"28","author":"Nathenson","year":"2018","journal-title":"Int J Gynecol Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:20:50Z","timestamp":1746336050000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":25,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030607","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}